Enter a Ticker Symbol To Get Your Free Bull/Bear Rating & Ranking Report from "Stock Scientist" Mike Turner

Dividend Quote

GNPX

Genprex Inc

Add to Scorecard

New Report from the Award-winning Analyst Who Beat the Market Over 15 Years

(For Privacy Policy visit us here)
*Note: You will not be spammed, ever. Period.

GNPX:Genprex Inc - Stock Quote and Dividend Data

LATEST CLOSE PRICE

$1.17

EXCHANGE

NASDAQ

SECTOR

Health Care

GNPX
Genprex Inc Dividend Information
Trailing 12 Month Dividend Yield0.00%
Projected 10 Year Dividend Yield0.00%
Dividend Yield 5 Year Average0.00%
Dividend Rate$0.00
Dividend Payout Ratio0.00%
Dividend Payout Ratio 5 yr Average0.00%
Dividend Growth Rate 3 yr Average0.00%
Dividend Growth Rate 5 yr Average0.00%
Dividend AllStar™ Ranking
Consecutive Dividend Increases0 Years

Dividend Payment TypeNone
Dividend Declaration DateNone
Dividend Ex DateNone
Dividend Record DateNone
Dividend Pay DateNone
Dividend Amount Current$0.000
Dividend Amount Previous$0.000
Dividends Paid in the Last 12 Months0
First Dividend PaidNone

FREE INVESTOR BRIEFING

Collect an 8% Yield on this "Government Mandated Income Opportunity"

(For Privacy Policy visit us here)
*Note: You will not be spammed, ever. Period.
GNPX
Genprex Inc Stock Information
Latest Close Price$1.17
52-Week Low/High$1.09 - $19.45
Percent Held by Institutions0.00%
Revenue$0
Net Income$-11,793,967
Cash Flow$-1,470,722
EPS-0.15%
Market Cap$17,635,410
PE Ratio0
PE Ratio to Industry62%
Debt-Equity Ratio0.00%
Debt-Equity to Industry1.39%
Total Return Last 12 Months0.00%
Total Return Last 3 Years0.00%
Total Return Last 5 Years0.00%
Latest Trade DateDec. 14, 2018
GNPX
Genprex Inc Dividend Payment History

No Data available for Payment History.

GNPX
Genprex Inc Other Details

Genprex is a clinical stage gene therapy company engaged in the treatment of cancer through its proprietary technology platform, including its initial product candidate, Oncoprex™ immunogene therapy. Co.'s platform technologies are designed to administer cancer fighting genes by encapsulating them into nanoscale hollow spheres which are then administered intravenously and taken up by tumor cells where they express proteins that are missing or found in low quantities. Co. holds an exclusive worldwide license from The University of Texas MD Anderson Cancer Center to patents covering the therapeutic use of a series of genes that have been shown to have cancer fighting properties.

Web Sitewww.genprex.com
SectorHealth Care
SegmentPharmaceuticals & Biotechnology
IndustryBiotechnology
Dividend AllStar™ Ranking
Dividend Re-Investment PlanNo
Re-Investment AgentNone
Direct Purchase Minimum$0
Optional Cash Pay Min-Max$0 - $0
Optional Cash Payment FrequencyNone
Dividend Tools

Building a successful dividend income portfolio is simple… if you have the right tools at your disposal. Here’s a sampling of Dividend Investor’s Dividend Tools, used by thousands of investors across the globe to gain a substantial edge in their portfolio strategies.

Dividend AllStar™ Ranking

Find stocks with consecutively increasing dividends:

  • = 5 years of dividend increases
  • = 10 years of dividend increases
  • = 20 years of dividend increases

Click to Learn More

Monthly Dividend Directory

Learn which investments pay out every month, including:

  • Dividend yield
  • Ex-dividend date
  • Dividend payout date… and more

Click to Learn More

Stock Screening Tools

Screen and filter thousands of dividend-paying investments with Dividend Investor’s advanced screening tools:

  • Dividend Payout Ratio
  • Consecutive Increases
  • 5-Year Total Return… and more

Click to Learn More

Try Dividend Investor PREMIUM for as low as $29

  • Dividend Allstars™ Tool
  • Proprietary Ex-dividend Calendar
  • Dividend Scorecard™ Portfolio Tracker
  • Customized Dividend Stock Screener
  • 4 FREE special reports from leading dividend experts
  • And much more...
 
Genprex Inc Dividend Stock News and Updates

Dec. 05, 2018CLOSE PRICE DECREASE: Genprex Inc (NASDAQ: GNPX) on 12-05-2018 decreased close price > 10% from $1.39 to $1.23

Read more...

Nov. 30, 2018CLOSE PRICE INCREASE: Genprex Inc (NASDAQ: GNPX) on 11-30-2018 increased close price > 10% from $1.32 to $1.65

Read more...

Nov. 14, 201852 WEEK LOW: Genprex Inc (NASDAQ: GNPX) on 11-14-2018 hit a 52 week low of $1.40

Read more...
More Genprex Inc Dividend News
Biotechnology Dividend Stock News and Updates

Dec. 15, 2018CLOSE PRICE DECREASE: Advaxis Inc (NASDAQ: ADXS) on 12-15-2018 decreased close price > 10% from $0.38 to $0.24

Read more...

Dec. 15, 2018CLOSE PRICE DECREASE: Anthera Pharmaceuticals Inc (OTCBB: ANTH) on 12-15-2018 decreased close price > 10% from $0.05 to $0.03

Read more...

Dec. 15, 2018CLOSE PRICE INCREASE: AVAX Technologies, Inc. (OTCBB: AVXT) on 12-15-2018 increased close price > 10% from $0.00 to $0.00

Read more...
More Biotechnology Dividend News
FREE REPORT
X
Bryan Perry Dividend Income Expert Bryan Perry

Earn 8% on this "Government Mandated Income Opportunity"

X

Search Dividend Investor